Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5887625 | Seminars in Arthritis and Rheumatism | 2014 | 7 Pages |
Abstract
This meta-analysis suggests that IAHA is not significantly different from continuous oral NSAIDs at 4 and 12 weeks. Our study detected no safety concerns; however, the included trials had only a short follow-up duration. Given the favorable safety profile of IAHA over NSAIDs, this result suggests that IAHA might be a viable alternative to NSAIDs for knee OA, especially for older patients at greater risk for systemic adverse events.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Raveendhara R. MD, FAGE, Elizaveta E. MD, MS, Matthew C. BA, Timothy E. MD, MPH,